Last updated: 2026-09-05 23:27:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
PERRIGO COMPANY PLC (PRGO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $14.92, with a market capitalization of $2.01B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.23 to $23.68. This page covers its latest market performance, valuation, price trends and company information.
$2.01B | |
$14.07 | |
$215.73 | |
$9.23 | |
$14.27 | |
1.78M | |
-- | |
-- | |
$23.68 | |
$9.23 | |
-- | |
-- |
PERRIGO COMPANY PLC (PRGO) last closed at $14.27 as of 2026-09-04 23:31:00, unchanged from the previous close of $14.27.
During the latest regular trading session, PRGO traded between $9.23 and $215.73, with a volume of 1.78M shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, PERRIGO COMPANY PLC (PRGO) moved from $14.34 to $14.92, representing a gain of 4.01% ($0.57).
The stock traded between $14.07 and $14.99 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 2.61 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 39.4%
PRGO is currently trading at $14.92, placing it 39.4% of the way from its 52-week low of $9.23 to its 52-week high of $23.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of PERRIGO COMPANY PLC (PRGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.